GT Biopharma Inc logo

GT Biopharma Inc

NEW
LTS:0RU9 (USA)  
€ 1,147,194 (0%) Aug 7
At Loss
P/B:
1.43
Market Cap:
€ 10.02M ($ 11.58M)
Enterprise V:
€ 2.27M ($ 2.63M)
Volume:
0
Avg Vol (2M):
0
Trade In:

GT Biopharma Inc Valuation Measures